Nimesulid Mcc (Nimesulide)

Nimesulide, the active ingredient in Nimesulid Mcc, is an NSAID presented as a tablet for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for adults with mild to moderate pain or inflammation.

GNH USA supplies Nimesulid Mcc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nimesulide acts on inflammatory pathways to relieve symptoms in several common conditions. - Pain relief: reduces mild to moderate acute pain such as dental or musculoskeletal discomfort. - Inflammation reduction: diminishes swelling and inflammation in conditions like sprains or soft‑tissue injuries. - Fever reduction: lowers elevated body temperature associated with febrile illnesses.

Nimesulide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild pruritus. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or jaundice. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury. - Allergic anaphylaxis: rapid onset of respiratory or circulatory collapse. - Blood dyscrasias: agranulocytosis or thrombocytopenia.

Before prescribing Nimesulide, consider the following safety measures. - Liver function monitoring: assess baseline enzymes and repeat if therapy is prolonged. - Renal function assessment: evaluate creatinine clearance in patients with kidney disease. - Gastrointestinal risk: avoid in individuals with active ulcers or a history of severe GI bleeding. - Concomitant NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs to reduce toxicity risk. - Pregnancy and lactation: avoid use unless clearly indicated by a healthcare professional. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Nimesulide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Hepatotoxic drugs (e.g., isoniazid, methotrexate): heightened liver injury potential. - CYP2C9 inhibitors (e.g., fluconazole): may raise Nimesulide plasma levels.

Moderate Interactions (Monitor Closely): - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Diuretics and ACE inhibitors: possible reduction in renal perfusion. - Lithium: NSAIDs may increase lithium concentrations. - Corticosteroids: enhanced risk of ulceration.